ArticleInternational journal of clinical and experimental pathology2017
The role and function of matrix metalloproteinase-8 in rhegmatogenous retinal detachment.
Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms.International journal of molecular sciences · 2022Review
- Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).International journal of molecular sciences · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhegmatogenous retinal detachment (RRD) is one blinding disease, and has pathological features correlated with migration of retinal pigment epithelium (RPE) cells to viscous body. Matrix metalloproteinase-8 (MMP-8) participates in eye diseases including xerophthalmia and retinal disease. Its role in RRD, however, has not been illustrated with the functional mechanism. RPE cells from RRD model mice and normal mice were separated and cultured. MMP-8 expression plasmid was transfected into RPE cell in model group. Real time PCR and Western blot were employed to test expression level of MMP-8, whilst MTT method was used to test proliferation activity of RPE cells. Caspase 3 activity was quantified by test kit. Transwell migration assay was adopted to measure invasion ability of RPE cells. ELISA method was used to test expression level of inflammatory factors interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). MMP-8 expression level was significantly decreased in RPE cells of RRD group, which also had enhanced cell proliferation and migration, accompanied with higher IL-1β and TNF-α levels (P<0.05 compared to control group). After MMP-8 transfection and over-expression, RPE cell proliferation and migration were inhibited, along with higher Caspase 3 activity, plus lower IL-1β and TNF-α expression (P<0.05 compared to model group). RRD caused decreased expression of MMP-8 in RPE cells. MMP-8 can facilitate RPE cells proliferation and migration via modulating cell apoptotic activity and secretion of inflammatory factor, thus participating in RRD pathogenesis and progression.
Indexed as
Identifiers
31966572PMC6965224W3005142285What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.